HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
104.27
+0.32 (0.31%)
At close: Aug 20, 2026, 4:00 PM EDT
102.92
-1.35 (-1.29%)
Pre-market: Aug 21, 2026, 7:46 AM EDT

HealthEquity Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, HealthEquity stock has a consensus rating of "Strong Buy" and an average price target of $118.53. The average 1-year stock price forecast is 13.68% higher than the current stock price, while the lowest is $105 (+0.70%) and the highest is $135 (+29.47%).

Price Target: $118.53 (+13.68%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$105$118.53$120$135
Change+0.70%+13.68%+15.09%+29.47%

Analyst Ratings

The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy91010101010
Buy555555
Hold100000
Sell000000
Strong Sell111100
Total161616161515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
KeyBanc
KeyBanc
Buy
Maintains
$125
BuyMaintains$125+19.88%Aug 18, 2026
BTIG
BTIG
Buy
Maintains
$110$115
BuyMaintains$110$115+10.29%Jul 24, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$125
BuyMaintains$125+19.88%Jul 9, 2026
RBC Capital
RBC Capital
Buy
Maintains
$108
BuyMaintains$108+3.58%Jul 9, 2026
Barclays
Barclays
Buy
Reiterates
$110
BuyReiterates$110+5.50%Jul 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.42B
from 1.31B
Increased by 7.74%
Revenue Next Year
1.52B
from 1.42B
Increased by 7.74%
EPS This Year
4.72
from 4.00
Increased by 17.98%
EPS Next Year
5.45
from 4.72
Increased by 15.43%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJan 31, 2022Jan 31, 2023Jan 31, 2024Jan 31, 2025Jan 31, 2026Jan 31, 2027
Revenue
756.56M861.75M999.59M1.20B1.31B1.42B
Revenue Growth
3.13%13.90%16.00%20.03%9.47%7.74%
Gross Profit
424.77M491.94M622.64M777.26M913.12M1.02B
Gross Margin
56.14%57.09%62.29%64.78%69.52%72.08%
Operating Income
40.57M37.65M128.13M202.87M327.48M375.99M
Net Income
-44.29M-26.14M55.71M96.70M215.20M249.70M
EPS
----4.004.72
EPS Growth
----28.21%17.98%
Forward PE
40.2736.7628.5531.7019.7522.10
Free Cash Flow
69.70M69.65M211.89M-145.32M338.05M429.88M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High1.4B
Avg1.4B
Low1.4B

Revenue Growth

Revenue Growth202720282029
High
8.1%
Avg
7.7%
Low
7.3%

EPS Forecast

EPS202720282029
High4.83
Avg4.72
Low4.66

EPS Growth

EPS Growth202720282029
High
20.8%
Avg
18.0%
Low
16.5%